Abstract: 1) Fungicidal compositions comprising: a) at least one pyridylmethylbenzamide derivative of formula (I), in which the various radicals are as defined in the description, and b) at least one compound (II) chosen from dithiocarbamates, preferably fungicidal dithiocarbamates, and, still more preferably from the following active agents: ferbam, mancopper, mancozeb, maneb, metiram, nabam, nickel bis(dimethyldithio-carbamate), propineb, zineb and mixtures thereof; and their agriculturally acceptable isomers and addition salts with an acid. 2) Method for the curative or preventive control of phytopathogenic fungi of crops using an effective and non-phytotoxic quantity of one of these fungicidal compositions.
Abstract: Nitrobenzene is produced and then purified using an acidic wash, an alkaline wash, a neutral wash, subjecting a dispersion formed in the neutral wash to electrophoresis to separate water and benzene from the nitrobenzene and recover purified nitrobenzene.
Type:
Grant
Filed:
January 30, 2007
Date of Patent:
February 5, 2008
Assignee:
Bayer MaterialScience AG
Inventors:
Thomas Knauf, Franz-Ulrich Von Gehlen, Jörg Schmiedler, Klaus Pilarczyk, Peter Drinda
Abstract: The present invention relates to a process for the preparation of a solid, orally administrable pharmaceutical composition, comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide in hydrophilized form, the pharmaceutical composition resulting from this process, and its use for the prophylaxis and/or treatment of thromboembolic diseases.
Abstract: The invention relates to cyclic depsipeptides, especially 18-membered cyclohexadepsipeptides of general formula (I) and the salts thereof, wherein R1 represents nitrobenzyl or R?R?N-benzyl—wherein R? and R? independently represent hydrogen, optionally substituted C1-C4-alkyl, formyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-alkoxycarbonyl, or hydroxy-C1-C2-alkyl-sulfonyl-C1-C2-alkyl, or, together with the nitrogen atom to which they are bound, R? and R? form an optionally substituted monocyclic or polycyclic, optionally bridged and/or spirocyclic, saturated or unsaturated heterocycle containing between one and three other heteroatoms from the group of nitrogen, oxygen and sulphur, or R? and R? together form C3-C5-alkylene monocarbonyl or an optionally susbtituted diacyl radical of a C4-C6-dicarboxylic acid—and R2, R3 and R4 independently represent C1-C4-alkyl.
Abstract: The invention relates to novel insecticidal active compound combinations comprising, firstly, cyclic ketoenols or other acaricidally active compounds and, secondly, further insecticidally active compounds from the group of the anthranilamides, which combinations are highly suitable for controlling animal pests, such as insects and unwanted acarids.
Type:
Application
Filed:
October 10, 2004
Publication date:
January 31, 2008
Applicant:
BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Inventors:
Christian Funke, Thomas Bretscheneider, Reiner Fischer, Rudiger Fischer, Heike Hungenberg, Wolfram Andersch, Wolfgang Thielert, Anton Kraus
Abstract: A method of selectively controlling morning glory spp., by treating a lower portion of a hill of morning glory spp. with one compound or a combination of two or more compounds selected from glufosinate, L-glufosinate, bialaphos, paraquat, diquat and agriculturally acceptable salts of the compounds.
Abstract: 1. Chimeric gene containing several herbicide tolerance genes, plant cell and plant which are tolerant to several herbicides. 2. The plant is tolerant to several herbicides at the same time, in particular to the inhibitors of HPPD and to those of EPSPS and/or to the dihalohydroxybenzonitriles. 3. Use for removing weeds from plants with several herbicides.
Type:
Application
Filed:
July 16, 2007
Publication date:
January 31, 2008
Applicant:
Bayer CropScience S.A.
Inventors:
Ken Pallett, Richard Derose, Bernard Pelissier, Alain Sailland
Abstract: The present invention provides a process for the double metal cyanide (DMC)-catalyzed production of low unsaturation polyethers from boron-containing starters. The polyethers produced by the inventive process may be reacted with one or more isocyanates to provide polyurethane products including coatings, adhesives, sealants, elastomers, foams and the like. The inventive process may be used to prepare fuel additives from C9-C30 boron-containing polyethers, more particularly from C13 alcohols.
Type:
Grant
Filed:
November 9, 2005
Date of Patent:
January 29, 2008
Assignee:
Bayer MaterialScience LLC
Inventors:
Jose F. Pazos, Kenneth G. McDaniel, Edward P. Browne, George G. Combs, Don S. Wardius
Abstract: A method for determining the presence and/or amount of an analyte in a sample of whole blood comprises the step of treating the sample with a nonlytic hypertonic salt composition to reduce the hematocrit by reducing the size of the red blood cells. In optical detection systems, the smaller red blood cells create greater scatter, which allows a more accurate correction to be applied in a dual-wavelength detection system. In electrochemical detection systems, as well as in optical detection systems, the smaller red blood cells provide less obstruction to the diffusion of analyte and reagents in the sample, to facilitate the reactions thereof.
Abstract: The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
Abstract: The present invention concerns a process for producing low-viscosity polyisocyanates or secondary products thereof, which carry activated, radiation-curable double bonds and can optionally also cure thermally, and low-viscosity polyisocyanate mixtures or secondary products thereof and their use in coating compounds.
Type:
Grant
Filed:
September 29, 2003
Date of Patent:
January 29, 2008
Assignee:
Bayer MaterialScience AG
Inventors:
Thomas Fäcke, Jan Weikard, Wolfgang Fischer
Abstract: A sensor dispensing instrument adapted to handle a sensor pack containing a plurality of sensors and to perform a test using one of the sensors. The sensor dispensing instrument includes an outer housing and display disposed on the outer housing for showing items. The sensor dispensing instrument further comprises a power button for turning the sensor dispensing instrument on and off, a scroll button for scroll through the items, and a select button for selecting an item.
Type:
Grant
Filed:
September 10, 2002
Date of Patent:
January 29, 2008
Assignee:
Bayer HealthCare LLC
Inventors:
G. Lamar Kirchhevel, Russell J. Micinski
Abstract: The invention describes a stirring device made from a gassing stirrer and a liquid mixer or two liquid mixers, which are arranged on a shaft and each have a feed and at least one exit opening, wherein the exit openings of the gassing stirrer and of the liquid mixer or the liquid mixers are at a distance from one another, the ratio, a/d, of the distance, a, between the exit openings to the diameter, d, of the gassing stirrer or liquid mixer being 0.02 to 0.5 and the ratio, b/d, of the distance, b, between the outer edges to the diameter, d, of the gassing stirrer or liquid mixer being 0.01 to 0.4.
Type:
Grant
Filed:
August 9, 2005
Date of Patent:
January 29, 2008
Assignee:
Bayer MaterialScience AG
Inventors:
Rainer Buse, Berthold Keggenhoff, Jürgen Münnig, Friedhelm Steffens, Joachim Ritter
Abstract: The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
Type:
Application
Filed:
February 15, 2005
Publication date:
January 24, 2008
Applicant:
Bayer HealthCare AG
Inventors:
Heike Gielen-Haertwig, Barbara Albrecht, Jorg Keldenich, Volkhart Li, Josef Pernerstorfer, Karl-Heinz Schlemmer, Leila Telan
Abstract: A method for producing storage media containing prerecorded structured information, which contains an order management and tracking system accessible via the Intranet/Internet, the conversion and/or selective extraction of searched structured information from different data sources into a universal data model, wherein the correlation of the information with the corresponding matching order from the order management and tracking system, and the provision of the storage media of any type, containing prerecorded structured information with unified format.
Type:
Application
Filed:
February 19, 2005
Publication date:
January 24, 2008
Applicant:
Bayer Business Services GMBH
Inventors:
Birte Achten, Frank Augustin, Oliver Gebert, Stephan Kohl, Christoph Schaub, Michael Schimeczek, Achim Zielesny
Abstract: The present invention relates to the new use of the compound 5-methoxy-4-methyl-2-[(4-methoxycarbonyl-2-methylthien-3-yl)sulfonylaminocarbonyl]-2,4-dihydro-3H-1,2,4-triazol-3-one of the formula (I) and/or of salts of the compound of the formula (I) for selectively controlling weeds of the genus Apera in crops of useful plants, and also to the corresponding agricultural method.
Type:
Application
Filed:
February 19, 2005
Publication date:
January 24, 2008
Applicant:
Bayer Cropscience AG
Inventors:
Markus Dollinger, Frederic Top, Ernst Gesing, Erwin Hacker
Abstract: Novel pyrazolopyrimidines of the formula in which R1, R2, R3, R4, R5 and Hal are as defined in the description, a plurality of processes for preparing these compounds and their use for controlling unwanted microorganisms.
Type:
Application
Filed:
December 8, 2004
Publication date:
January 24, 2008
Applicant:
BAYER CROPSCIENCE AKTIENGESELLSCHSFT
Inventors:
Olaf Gebauer, Ulrich Heinemann, Stefan Herrmann, Herbert Gayer, Jorg Nico Greul, Stefan Hillebrand, Hans-Ludwig Elbe, Ronald Ebbert, Ulrike Wachendorff-Neumann, Peter Dahmen, Karl-Heinz Kuck
Abstract: The invention is a method and an apparatus for continuously controlling denitrification in wastewater purification in a sewage treatment plant having at least one denitrification stage under varying nitrogen loads comprising the steps a) provision of excess sludge, b) treatment of the excess sludge according to running parameters determined in advance, c) separation of the treated excess sludge into an organic fraction and an inorganic fraction, d) measurement of actual values for dissolved organic carbon (DOC) in the organic fraction, e) recirculation of the organic fraction to one of the denitrification stages, f) comparison of actual values with predetermined setpoint values for DOC fractions and, in the event of difference between actual values and setpoint values, determination of altered running parameters for treatment of the excess sludge in step b), g) repetition of steps a), to f).
Type:
Application
Filed:
June 16, 2005
Publication date:
January 24, 2008
Applicant:
Bayer Healthcare AG
Inventors:
Jurgen Kahlert, Frank Niemeyer, Matthaus Schmidt
Abstract: A process photometer which includes an insulated and a non-insulated compartment. The insulated compartment is maintained at a relatively constant, elevated temperature. The radiation source, a rotatable filter wheel, a radiation detector, and a means for converting analog output to a digital signal are among the components within the insulated compartment. The non-insulated compartment houses a power supply.
Type:
Grant
Filed:
December 22, 2004
Date of Patent:
January 22, 2008
Assignee:
Bayer MaterialScience LLC
Inventors:
Robert N. Hunt, Atul Khettry, Matthew R. Vila